1. Home
  2. KVHI vs ELTX Comparison

KVHI vs ELTX Comparison

Compare KVHI & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$9.53

Market Cap

188.0M

Sector

Technology

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

BUY

Current Price

$4.11

Market Cap

185.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
KVHI
ELTX
Founded
1978
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.0M
185.4M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
KVHI
ELTX
Price
$9.53
$4.11
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$18.00
AVG Volume (30 Days)
333.0K
3.2M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
39.29
EPS
0.03
N/A
Revenue
$9,622,000.00
$2,301,000.00
Revenue This Year
$28.90
N/A
Revenue Next Year
$31.85
N/A
P/E Ratio
$308.67
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$2.66
52 Week High
$13.00
$16.00

Technical Indicators

Market Signals
Indicator
KVHI
ELTX
Relative Strength Index (RSI) 53.42 32.85
Support Level $8.80 N/A
Resistance Level $10.63 $9.95
Average True Range (ATR) 0.68 1.52
MACD 0.17 -1.04
Stochastic Oscillator 81.85 10.79

Price Performance

Historical Comparison
KVHI
ELTX

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: